Bright light therapy in Parkinson's disease: a pilot study on visual pathway improvements

Area of Science:

• Neuroscience
• Ophthalmology
• Neurology

Background:

• Bright light therapy (BLT) shows promise for Parkinson's disease (PD), but its mechanisms are unclear.
• Visual pathway improvements may underlie BLT's efficacy in PD.

Purpose of the Study:

• To evaluate BLT's effect on clinical symptoms in Parkinson's disease.
• To investigate the mechanisms of visual pathway changes using OCT, PERG, and VEP.

Main Methods:

• A crossover randomized placebo-controlled study involving 23 PD patients.
• Interventions included one month of BLT or dim light therapy (DLT) with a wash-out period.
• Clinical scales and visual function tests (OCT, PERG, VEP) were assessed before and after each intervention.

Main Results:

• BLT improved excessive daytime sleepiness, anxiety, quality of life, and autonomic function.
• BLT enhanced pattern electroretinogram (PERG) and visual evoked potentials (VEP) in PD patients compared to DLT.
• No significant changes in retinal nerve fiber layer thickness were observed.

Conclusions:

• BLT is a safe and effective non-pharmacological treatment for improving visual function in Parkinson's disease.
• BLT's benefits may be mediated through improvements in the visual pathways.